Scout24 AG (0RB8)
London Exchange · UK · prices in EUR · close of 23 Oct 2026
Key indicators
| Last close | EUR 84.95 |
|---|---|
| 52-week range | 62.65 – 102.80 |
| Return, 1 month / 3 months | +19.6% / +26.6% |
| Return, 1 year / 3 years | −15.2% / +49.2% |
| Trend | Uptrend |
| RSI (14) | 77 |
| Volatility (1 year) | 33.7% |
| Worst drawdown (1 year) | -38.4% |
| Average daily value traded | 14.78M EUR |
| Dividend yield | 1.8% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Scout24 is a German digital company that runs online marketplaces connecting people with property and vehicles. Its ImmoScout24 platform brings together estate agents, landlords and people looking for homes to rent or purchase, while AutoScout24 serves dealers and private individuals trading cars. The business also offers related digital services for professional customers. Scout24 is based in Munich and focuses mainly on the German-speaking market, earning revenue from advertising and subscription packages offered to its business users.
Scout24 AG trades under the code 0RB8 on the London Exchange in UK, with its price quoted in euros (EUR). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Scout24 AG (0RB8) trades on the London Exchange in UK. It last closed at EUR 84.95 on 23 October 2026.
Its price-based Market X-Ray is 58 out of 100 (a fair price profile), ranking 1,490 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price fell 15.2% and over the last three months it rose 26.6%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 66 · Fair | Mixed trend against its averages. | |
| Above 200-day average | 16.7% | ||
| From 52-week high | -16.9% | ||
| Momentum | 64 · Fair | Typical recent returns for this exchange. | |
| 3-month return | 26.6% | ||
| 6-month return | 24.3% | ||
| 12-month return, skipping the last month | -29.1% | ||
| Stability (higher is calmer) | 43 · Weak | Volatile, with deep drawdowns. | |
| Volatility, 1 year (lower is calmer) | 33.7% | ||
| Worst drawdown, 1 year (smaller is calmer) | -38.4% | ||
| Liquidity | 77 · Strong | Trades actively. | |
| Average daily value traded | 14.78M EUR | ||
| Zero-volume days | 3.3% | ||
| Income | 35 · Weak | Dividend is small or irregular. | |
| Dividend yield | 1.8% | ||
| Years with dividends | 5 |
Strengths
- Liquidity: Trades actively.
Weak spots
- Stability (higher is calmer): Volatile, with deep drawdowns.
- Income: Dividend is small or irregular.
Returns
| 1 week | +6.4% |
|---|---|
| 1 month | +19.6% |
| 3 months | +26.6% |
| 6 months | +24.3% |
| 1 year | −15.2% |
| 3 years | +49.2% |
| 5 years | +48.4% |
Signals
| 50-day / 200-day average | 74.97 / 72.80 |
|---|---|
| Golden / death cross (60 days) | Golden, 36 days ago |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 2.99 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 18 Jun 2026 | EUR 1.5000 |
| 6 Jun 2025 | EUR 1.3200 |
| 6 Jun 2024 | EUR 1.2000 |
| 23 Jun 2023 | EUR 1.0000 |
| 1 Jul 2022 | EUR 0.8500 |
| 9 Jul 2021 | EUR 0.8200 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.